Clinical research is the critical final step in making new technologies and treatments a reality for Australians living with T1D. The Australian T1D Clinical Research Network (CRN) accelerates this process and encourages collaboration and shared learning on an unprecedented scale.


In 2010 the Australian Government's Department of Health and Ageing awarded $5M in funding to JDRF to establish the CRN, with $35M allocated in 2014 through a Special Research Initiative of the Australian Research Council. The CRN is connecting 1500 Australians to the latest treatments and technologies, 250+ researchers to each other, allowing 70+ institutions to share insights through 15 high impact studies. In addition, the program nurtures emerging research leaders through funding and mentoring helping to secure the future of Australian T1D research. 


The potential of this network to improve the lives of those living with T1D, both in Australia and globally and to ultimately find a cure is remarkable. We are closer than ever before to a world without T1D. 


Please scroll down to view the steps along the journey.


More than 235 researchers now connected to the network

  1. - More than 65 institutes connected

  2. - $28M+ funding committed to-date clinical research, innovation and collaboration to progress research

  3. - $350K in seed funding for early research on innovative concepts

  4. - Launch of T1D Game Changer

  5. - ENDIA recruitment reaches over 700 participants


- $4.5M committed to Innovation Awards - new directions to cure, treat and prevent T1D

More than 215 researchers connected to the network 

- 63 institutes connected

- $26M funding committed to clinical research, innovation and collaboration

- Next generation research leaders awarded almost $2M


- $14M in competitive grants allocated to five multi-state high impact clinical trials

35 research institutions and universities connected to the network

More than 50 researchers supported in local jobs 
- ENDIA begins recruiting 1400 pregnant women and their infants 

- The Australasian Diabetes Data Network (ADDN) builds from 4000 children in the Network to 6000 

- 19 clinical centres joined four consortia in the areas of glucose control, prevention, complications and cure


- The Federal Government commits a further $35M over five years

- 43 key opinion leaders develop the research strategy and implementation plan
- Major international partnership with US based Leona M. and Harry B. Helmsley Charitable Trust 

- The Trust provides $4M towards the ENDIA  study


- 100% of the $5M in funding is committed to research projects, talent and building the case for the future

Three large clinical trials

- The formation of a unique national diabetes data network, the Australasian Diabetes Data Network (ADDN)

Nine Pilot and Feasibility projects awarded

- Five Mentored Clinician Researcher Fellowships established, nurturing the next generation of researchers


 - $350K with Macquarie Group Foundation for a world first study testing a fibre supplement in adults with T1D

250+ researchers connected to the network

70+ institutes connected
$29.4M in funding committed to-date clinical research, innovation and collaboration

- Two next generation research leaders awarded fellowships
- Environmental Determinants of Islet Autoimmunity (ENDIA)  recruitment reaches 1000 participants

- The Helmsley Charitable Trust awards almost $3M in funding towards two prevention projects

Almost $500K towards supporting translational research in Australia to bring new therapies to people sooner